UCB (EBR:UCB) UCB Media Room: Transparency notification UCB SA/NV

Directive transparence : information réglementée

07/04/2021 20:05
https://mb.cision.com/Public/18595/logo/86a99b25f755738d_org.jpg ** Transparency notification UCB SA/NV ------------------------------------------------------------ =C2=B7 Notification referring to situation on 1 April 2021 =C2=B7 Threshold crossed: 3% =C2=B7 Latest holding: 2.83% Brussels (Belgium), 7 April 2021 =E2=80=93 20:00 (CEST) =E2=80=93 regulated= information 1.=C2=A0=C2=A0Summary of the notification Pursuant to Article 14 of the law of 2 May 2007 on the disclosure of large = shareholdings, UCB SA/NV announces that it has filed a transparency notific= ation. The transparency notification dated 7 April 2021 has been submitted in acco= rdance with Article 18 juncto Article 6 of the law of 2 May 2007 on the dis= closure of large shareholdings, due to UCB covering its obligations towards= employees in the framework of the Long Term Incentive plans of the UCB gro= up. As a result thereof, voting rights relating to voting securities held b= y UCB SA/NV crossed downwards the 3% threshold on 1 April 2021.=C2=A0 On 1 April 2021, UCB SA/NV owned 5 508 556 UCB shares with voting rights (v= ersus 5 855 888 UCB shares in its previous notification dated 29 March 2021= ), representing 2.83% of the total number of shares issued by the company (= 194 505 658) (versus 3.01% in the notification dated 29 March 2020).=C2=A0 2.=C2=A0=C2=A0Content of the notification =C2=B7 Reason for the notification: Acquisition or disposal of voting secur= ities or voting rights =C2=B7 Notification by: A person that notifies alone =C2=B7 Person subject to the notification requirement:=C2=A0 =C2=A0https://mb.cision.com/Public/18595/3321279/b8cb6c1e21f71479_800x800ar= .png =C2=B7 Date on which the threshold is crossed: 1 April 2021 =C2=B7 Threshold crossed (in %): 3%Denominator: 194 505 658 =C2=B7 Notified details: =C2=A0https://mb.cision.com/Public/18595/3321279/983ee51e1ebcea8d_800x800ar= .png =C2=A0 =C2=B7 =C2=A0Additional information:=C2=A0 The disclosure obligation arose due to voting rights held by UCB SA crossin= g downwards the 3% minimum threshold. The variation is due to UCB covering = its obligations towards employees in the framework of the Long Term Incenti= ve plans of the UCB group.=C2=A0 3.=C2=A0=C2=A0Further information This press release and the detailed transparency notification are available= on UCB SA/NV=E2=80=99s website via the following link (https://www.ucb.com= /investors/UCB-shareholders) . An updated overview of the UCB SA/NV large shareholdings will be available = on UCB SA/NV=E2=80=99s website via the following link (https://www.ucb.com/= investors/UCB-shareholders) . Investor Relations Antje Witte =C2=A0 =C2=A0 =C2=A0 =C2=A0 =C2=A0 Investor Relations, UCB T +32.2.559.94.14 antje.witte@ucb.comIsabelle Ghellynck, Investor Relations, UCB T+32.2.559.9588, isabelle.ghellynck@ucb.com=C2=A0 About UCB UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company = focused on the discovery and development of innovative medicines and soluti= ons to transform the lives of people living with severe diseases of the imm= une system or of the central nervous system. With approximately 8 400 peopl= e in nearly 40 countries, the company generated revenue of =E2=82=AC 5.3 bi= llion in 2020. UCB is listed on Euronext Brussels (symbol: UCB). Follow us = on Twitter: @UCB_news GenericFile 210407- Transparantieverklaring persbericht UCB (https://mb.cision.com/Publ= ic/18595/3321279/a066539f3dfef890.pdf) GenericFile 210407 - Transparency notification UCB SA (https://mb.cision.com/Public/185= 95/3321279/bd5540ea22ccb50a.pdf) GenericFile 210407- Communication de presse UCB SA (https://mb.cision.com/Public/18595/= 3321279/86571c8a732803c6.pdf) Image Chart 1 April 7 2021 (https://mb.cision.com/Public/18595/3321279/b8cb6c1e21= f71479_org.png) Image Chart 2 April 7 2021 (https://mb.cision.com/Public/18595/3321279/983ee51e1e= bcea8d_org.png)=0D =0D ______________________=0D If you would rather not receive future communications from UCB SA, please g= o to https://eu.vocuspr.com/OptOut.aspx?2973226x20421x65905x1x6868579x24000= x6&Email=3Dregnews%40symexglobal.com.=0D UCB SA, All=C3=A9e de la Recherche, 60 ., Brussels, . B - 1070 Belgium=